| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |